22nd October 2015, SomnoMed Limited
(ASX:SOM) is proud to announce that it passed the milestone of having fitted over one quarter of a million patients with SomnoDent® devices since its inception. Of these approximately 140,000 patients reside in the US and Canada; 70,000 in Europe and 40,000 in the Australia-Pacific region. Whilst it took 71⁄2 years to reach 180,000, it took only a further 16 months to exceed the 250,000 patients milestone.
“To have exceeded a quarter of a million patients is an important event in SomnoMed’s history,” said Dr. Peter Neustadt, Executive Chairman of SomnoMed. “It is not only a sign of the success of our treatment and the rapidly growing acceptance of our COATTM alternative to CPAP, it is a very important element in proving the medical history SomnoMed has created over the years. Over all these years and with an impressive patient pool, SomnoMed is proud that it has been able to provide an effective, safe and more patient friendly treatment of obstructive sleep apnea (OSA) than is otherwise available.”
For further information please download PDF attached:
